comparemela.com

Latest Breaking News On - Biopharma group - Page 2 : comparemela.com

Mereo BioPharma to Participate in Fireside Chat at the

Mereo BioPharma to Participate in Fireside Chat at the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Insider Selling: Mereo BioPharma Group plc (NASDAQ:MREO) Insider Sells $298,283 04 in Stock

Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) insider Alexandra Hughes-Wilson sold 100,432 shares of Mereo BioPharma Group stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $2.97, for a total transaction of $298,283.04. Following the sale, the insider now owns 32,568 shares in […]

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Set for Significant Growth

The global alpha-1 antitrypsin deficiency (AATD) augmentation therapy market is projected to reach USD 2,517 million by 2032, up from USD 1,413 million in 2022, growing at a CAGR of 6.1% during the forecast period from 2022 to 2032. This growth is driven by several key factors, including increasing awareness of AATD.

Mereo BioPharma Group (NASDAQ:MREO) Receives Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a research report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price on the stock. Separately, Needham & Company LLC reaffirmed a buy rating and set a $6.00 price objective on shares of […]

Mereo BioPharma Group (NASDAQ:MREO) Rating Reiterated by Cantor Fitzgerald

Mereo BioPharma Group (NASDAQ:MREO – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports. They presently have a $7.00 target price on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 113.41% from the company’s current […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.